Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma

Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma

(2017) Hilary R. Keller et al.   Oncotarget

Melanoma-derived factors alter the maturation and activation of differentiated tissue-resident dendritic cells

(2015) Kristian M Hargadon et al.   IMMUNOLOGY AND CELL BIOLOGY

Liposomes as nanomedical devices

(2015) Giuseppina Bozzuto et al.   International Journal of Nanomedicine

Immune Checkpoint Blockade in Cancer Therapy

(2015) Michael A. Postow et al.   JOURNAL OF CLINICAL ONCOLOGY

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

(2015) Stefani Spranger et al.   NATURE

Immunotherapy Combinations With Checkpoint Inhibitors in Metastatic Melanoma: Current Approaches and Future Directions

(2015) Michael Atkins   SEMINARS IN ONCOLOGY

The immune escape in melanoma: role of the impaired dendritic cell function

(2014) Marco Tucci et al.   Expert Review of Clinical Immunology

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular and genetic diversity in the metastatic process of melanoma

(2014) Katja Harbst et al.   JOURNAL OF PATHOLOGY

Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?

(2014) Hisataka Kobayashi et al.   Theranostics

Dendritic Cell-Targeted Vaccines

(2014) Lillian Cohn et al.   Frontiers in Immunology

Immune Senescence and Vaccination in the Elderly

(2013) Pierre Lang et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Recall Responses to Tetanus and Diphtheria Vaccination Are Frequently Insufficient in Elderly Persons

(2013) Birgit Weinberger et al.   PLoS One

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY